444
Participants
Start Date
June 19, 2020
Primary Completion Date
April 1, 2023
Study Completion Date
April 1, 2023
Oral
Diltiazem 0.25mg/kg injection, give over 2 minutes, max dose 30mg
Intravenous drug
these patients will receive traditional treatments at provider discretion. They must receive at least one intravenous medication for atrial fibrillation with rapid ventricular response. This will be a heterogenous group of patients receiving digoxin, amiodarone, various beta-blockers, and intravenous diltiazem without oral diltiazem.
Matthew Hysell, Saint Joseph
Spectrum Health - Lakeland
OTHER